Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Clinical Trials
Clinical trial results of drug in prostate, ovarian, breast cancer presented
June 23rd, 2005
Results from clinical studies of Yondelis (trabectedin) were presented at the annual meeting of the American Society of Clinical Oncology (ASCO), in Orlando, Florida. Yondelis is being developed by PharmaMar in partnership with Johnson & Johnson Pharmaceutical Research & Development, L.C.C. (J&JPRD). In addition, a poster was presented on a second PharmaMar anti-cancer drug, Kahalalide F. Results from a phase 2 study of a 3-hour weekly infusion of Yondelis (trabectedin) in patients with androgen-independent advanced prostate carcinoma were presented during an oral session by Dr. D. Michaelson of the Massachusetts General Hospital Cancer Center in...
Source: Women's Health Weekly (2005-06-23)
|
